HEXYON, hexavalent vaccine against diphtheria, tetanus, poliomyelitis, pertussis, Haemophilus influenzae type b infections, hepatitis B

INFECTIOLOGY - New medicinal product

Opinions on drugs - Posted on Oct 02 2015

Inclusion

HEXYON is a hexavalent vaccine which has Marketing Authorisation for the primary and booster vaccination against diphtheria, tetanus, poliomyelitis, pertussis, Haemophilus influenzae type b infections and hepatitis B, in infants from 6 weeks to 24 months of age.
There is another vaccine authorised in France for the primary and booster vaccination in infants: INFANRIX HEXA. The immunogenicity of HEXYON is not inferior to that of INFANRIX HEXA and its safety profile is comparable despite a higher frequency of local reactions.